FDA to explore importing drugs from overseas to lower prices

The Trump administration wants to explore how to safely import pharmaceuticals from other countries in order to counteract major hikes in the price of drugs. Such a policy would represent a major shift from current procedure.

Health and Human Services Secretary Alex Azar requested on Thursday that the Food and Drug Administration establish a working group to examine safe importation. The request is part of a larger effort by the Trump administration to tackle high drug prices, a growing driver of healthcare costs in the U.S.